A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment (Abstract in rivista)

Type

• Prodotto della ricerca (Classe)
• Abstract in rivista (Classe)

Label

• A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment (Abstract in rivista) (literal)

Anno

• 2009-01-01T00:00:00+01:00 (literal)

Alternative label

• Esposito, N; Colavita, I; Quarantelli, F; Izzo, B; Luciano, L; Del Vecchio, L; Hughes, T; Radich, J; Russo, D; Soverini, S; Iacobucci, I; Martinelli, G; Saglio, G; Melo, J; Ruoppolo, M; Kalebic, T; Pane, F (2009)
  A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment
  in , 2009
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Esposito, N; Colavita, I; Quarantelli, F; Izzo, B; Luciano, L; Del Vecchio, L; Hughes, T; Radich, J; Russo, D; Soverini, S; Iacobucci, I; Martinelli, G; Saglio, G; Melo, J; Ruoppolo, M; Kalebic, T; Pane, F (literal)

Titolo

• A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment (literal)

Prodotto di

• Institute of biostructure and bioimaging (IBB) (Istituto)
• Messa a punto di Metodiche Diagnostiche innovative di Imaging Quantitativo (ME.P06.004.002) (Modulo)

Autore CNR

• MARIO QUARANTELLI (Persona)
• BARBARA IZZO (Unità di personale interno)

Incoming links:

Autore CNR di

• BARBARA IZZO (Unità di personale interno)
• MARIO QUARANTELLI (Persona)

Prodotto

• Institute of biostructure and bioimaging (IBB) (Istituto)
• Messa a punto di Metodiche Diagnostiche innovative di Imaging Quantitativo (ME.P06.004.002) (Modulo)